Topic: respiratory diseases
The deal sees AstraZeneca join Novartis among Mereo’s shareholders and further its efforts to offload deprioritized drugs.
Propeller Health is launching an API, as well as a series of tools based on it, that provides information on local asthma conditions.
Acceleron's collaboration with Celgene on sotatercept has taken another turn, giving Acceleron the right to develop the drug for pulmonary diseases.
A first-in-class therapy developed by AstraZeneca and Amgen looks like a strong treatment candidate for severe uncontrolled asthma, according to a respiratory specialist.
Australia's Adherium scored an FDA nod for its SmartTouch device, for use with AstraZeneca’s Symbicort inhalers.
The Big Pharma is paying €25 million to work with Ethris on respiratory diseases and bag the option to license the fruits of the collaboration.
Belgian biotech Galapagos has chalked up a positive phase 2a trial for its idiopathic pulmonary fibrosis (IPF) drug GLPG1690, saying it halted the relentless decline in lung function normally seen in patients.
The cull of will see GSK focus 80% of its R&D budget on the top candidates in four therapeutic areas and potentially exit the rare disease space.
A team led by Washington University in St. Louis has unraveled the structure of a protein that allows RSV to elude the immune system.